Precision BioLogic said Thursday it secured US Food and Drug Administration 510(k) premarket clearance for its Cryocheck Chromogenic Factor IX test for managing hemophilia B.

Foundation Medicine said Wednesday its FoundationOne Liquid CDx test has been approved by the US Food and Drug Administration as a companion diagnostic for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI).

Precision Medicine Asia and the National Cancer Center Hospital East in Japan are building a lung cancer clinicopathological genomic database and screening infrastructure that spans seven countries in the Asia-Pacific region, the groups said Wednesday.

Merck, known as MSD outside the United States and Canada, today announced that the U.S. FDA has granted Fast Track designation for Merck’s investigational anticoagulant therapy MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease.

April 5, 2022 – GE Healthcare and Elekta (EKTA-B.ST) announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology.

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

Some of the neurological symptoms associated with menopause are similar to early signs of dementia. The ability of MHT to alleviate such symptoms in some women has led scientists to question whether a link exists between specific hormone levels and dementia.

Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More

The increasing number of original reference biologics coming off patent over the past few years is well known within the pharmaceutical industry with 17 coming off patent in Europe between 20182023 (1). The result is a substantial increase

2019 CACLP Floorplan In Nanchang